Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Immunic, Inc. (IMUX) had Pre-Tax Income of $-26.82M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.82M |
|
-- |
|
-- |
|
$27.08M |
|
$-27.08M |
|
$0.26M |
|
|
Pre-Tax Income |
$-26.82M |
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-26.82M |
|
$-27.08M |
|
$-27.04M |
|
132.18M |
|
132.18M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$59.84M |
|
$0.61M |
|
$1.59M |
|
$61.43M |
|
$27.31M |
|
-- |
|
$0.20M |
|
$27.52M |
|
$33.91M |
|
$33.91M |
|
$33.91M |
|
98.65M |
|
| Cash Flow Statement Financials | |
$-46.38M |
|
$-0.08M |
|
$65.52M |
|
$35.67M |
|
$55.31M |
|
$19.64M |
|
$3.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-79.09% |
|
-79.09% |
|
-43.66% |
|
-79.09% |
|
$0.34 |
|
$-0.35 |
|
$-0.35 |
|